130 related articles for article (PubMed ID: 19331790)
1. Antihypertensive treatment and its implications on lipoprotein metabolism of patients in care by a hypertension and diabetes program in Brazil.
Martins RD; Alves Rde S; Silva GG; Martins N; Vasconcelos S; Assreuy A; Martins A; Goretti Queiroz M
Acta Med Port; 2008; 21(6):567-74. PubMed ID: 19331790
[TBL] [Abstract][Full Text] [Related]
2. The association between antihypertensive drug therapies and plasma lipid levels in the general population.
Maitland-van der Zee AH; Klungel OH; Kloosterman JM; Seidell JC; Leufkens HG; de Boer A
J Hum Hypertens; 2001 Oct; 15(10):701-5. PubMed ID: 11607800
[TBL] [Abstract][Full Text] [Related]
3. Effect of antihypertensive therapy on serum lipids in newly diagnosed essential hypertensive men.
Nandeesha H; Pavithran P; Madanmohan T
Angiology; 2009; 60(2):217-20. PubMed ID: 18445617
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
Cortez-Dias N; Martins S; Belo A; Fiuza M;
Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
[TBL] [Abstract][Full Text] [Related]
5. [Modification of lipoprotein metabolism by antihypertensive therapy].
Herrmann W; Reuter W
Z Gesamte Inn Med; 1989 Apr; 44(7):197-200. PubMed ID: 2662653
[TBL] [Abstract][Full Text] [Related]
6. [The treatment of hypertension in patients with a metabolic disorder].
Dal Palù C; Semplicini A
Ann Ital Med Int; 1995 Oct; 10 Suppl():130S-132S. PubMed ID: 8562259
[TBL] [Abstract][Full Text] [Related]
7. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
[TBL] [Abstract][Full Text] [Related]
8. [Effect of anti-hypertensive treatment on plasma lipids and lipoproteins (author's transl)].
Sauvanet JP; Rouffy J
Pathol Biol (Paris); 1981 Sep; 29(7):435-40. PubMed ID: 6117048
[TBL] [Abstract][Full Text] [Related]
9. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
10. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
[TBL] [Abstract][Full Text] [Related]
11. Overview and other metabolic issues and concerns in management of mild hypertension.
Chobanian AV
J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S483-6. PubMed ID: 6208416
[TBL] [Abstract][Full Text] [Related]
12. [Effect of ebrantil, a new antihypertensive agent, on lipid metabolism and electrolyte balance].
Mertz DP; Engelstätter R
Fortschr Med; 1982 Nov; 100(42):1978-82. PubMed ID: 6961094
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hypertension by general practitioners and antihypertensive drugs expenditure in an urban environment.
Marković BB; Kranjcević K; Stojanović-Spehar S; Blazeković-Milaković S; Kern J; Botica MV; Jelinić JD; Marković M
Coll Antropol; 2009 Mar; 33(1):71-6. PubMed ID: 19408606
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study.
Jong GP; Chang MH; Tien L; Li SY; Liou YS; Lung CH; Ma T
Cardiovasc Ther; 2009; 27(3):159-63. PubMed ID: 19689614
[TBL] [Abstract][Full Text] [Related]
15. [Antihypertensive drug therapy in relation to lipid disorders].
Kawecka-Jaszcz K; Stochmal A
Przegl Lek; 1998; 55(2):85-8. PubMed ID: 9695649
[TBL] [Abstract][Full Text] [Related]
16. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
[TBL] [Abstract][Full Text] [Related]
17. [Lipid control in diabetic patients in Extremadura (Spain)].
Roberto Robles N; Barroso S; Marcos G; Sánchez Muñoz-Torrero JF;
Endocrinol Nutr; 2009 Mar; 56(3):112-7. PubMed ID: 19627723
[TBL] [Abstract][Full Text] [Related]
18. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
[TBL] [Abstract][Full Text] [Related]
19. [Effect of anti-hypertensive treatment on plasma lipids and lipoproteins (author's transl)].
Sauvanet JP; Rouffy J
Sem Hop; 1982 Mar; 58(9):563-8. PubMed ID: 6121378
[TBL] [Abstract][Full Text] [Related]
20. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
Liou YS; Ma T; Tien L; Lin CM; Jong GP
Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]